Forget about Grey’s Anatomy and ER when you can go inside a real hospital.
does anyone know when this will take effect
The Best Summer TV Series Is ABC’s “Boston Med”
July 28th, 2010HCA’s $4.6 Billion IPO: Three Storylines To Follow
July 28th, 2010The HCA IPO could make hospitals a hot investing category. What did its private equity owners do to earn their pay?
like our content consider our rss feed!
Genzyme’s Hidden Value
July 28th, 2010The timing of Genzyme’s earnings growth is as important as the company’s overall sales when it comes to M&A.
thanks for delivering this story to me
Defending Fish Oil, Criticizing Glaxo
July 28th, 2010Steven Salzberg wrote earlier this week about GlaxoSmithKline’s marketing of fish oil, a supplement, as a drug in the form of its omega-3 fatty acid pill, Lovaza. I took issue with his post, because I think the data for the fish oil omega-3s, DHA and EPA, are pretty strong. (I’ve previously written about this here [...]
does anyone know the real story
The Sad Truth About $100,000 Cancer Drugs
July 28th, 2010An important New Yorker story focuses on the unfortunate reality of rare, expensive treatments: they fail most of the time.
how doe this impact my state
Dendreon Gets Some Respect
July 28th, 2010Pivotal Provenge results are published in the New England Journal of Medicine.
thanks for visiting today!
Sanofi-Aventis Setback Could Mean Generic Biotech Drugs Are On The Way
July 26th, 2010In a move with big implications for the biotech industry, the FDA has approved a generic version of Sanofi-Aventis’ injected blood thinner Lovenox.
thanks for visiting today!
Novartis Exec: Golden Age Of Generic Biotech Drugs Is Coming
July 26th, 2010The FDA’s surprise approval of Novartis’ generic version of the blood thinner Lovenox after a four-year review is a signal the FDA may be more willing to approve complex generic products in the coming years, says Jeffrey George, global head of Novartis’s Sandoz generic drug unit.
“It underscores that the FDA really does have the institutional [...]
company cost health insurance low orlando
Onyx’s Next Blockbuster?
July 26th, 2010Onyx says its multiple myeloma drug carfilzomib performed well in a clinical trial.
check out our ads below, they maybe of interest.
Fish Oil Salesmen
July 26th, 2010Lovaza is the only fish oil supplement with FDA approval. A new marketing campaign makes it sound special – but is it?
it should be interested what change will this make